Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4

Rhea-AI Filing Summary

Gilead Sciences Chief Commercial and Corporate Affairs Officer Johanna Mercier exercised restricted stock units and had shares withheld for taxes. On this date, 2,796 restricted stock units converted into 2,796 shares of common stock, while 1,341 shares were disposed of to cover tax obligations.

After these transactions, Mercier directly held 128,575 shares of common stock and 27,851 restricted stock units. The RSUs represent contingent rights to receive one share of common stock each and vest over four years, with 25% on the first anniversary of grant and the remainder vesting quarterly at 6.25% until fully vested.

Insights

Insider transactions specialist

Compensation-related RSU vesting with routine tax withholding.

Johanna Mercier exercised 2,796 restricted stock units into common shares and had 1,341 shares withheld to satisfy tax obligations. This is a typical pattern for equity compensation rather than an open-market purchase or sale, and the filing shows no discretionary trading.

Following these transactions, she holds 128,575 common shares and 27,851 restricted stock units, indicating a substantial ongoing equity position. The four-year vesting schedule, with 25% vesting after one year and 6.25% quarterly thereafter, ties a portion of her compensation to Gilead’s long-term performance.

Insider Trade Summary

2,796 shares exercised/converted

Mixed 3 txns

Insider Mercier Johanna

Role Chief Comm & Corp Aff Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	2,796	$0.00	--
Exercise	Common Stock	2,796	$0.00	--
Tax Withholding	Common Stock	1,341	$121.48	$163K

Holdings After Transaction: Restricted Stock Unit — 27,851 shares (Direct, null); Common Stock — 128,575 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Key Figures

RSUs exercised: 2,796 units Tax-withholding shares: 1,341 shares Common shares held after: 128,575 shares +3 more

6 metrics

RSUs exercised 2,796 units Restricted stock units converted into common stock

Tax-withholding shares 1,341 shares Shares delivered to satisfy tax liability

Common shares held after 128,575 shares Direct common stock ownership following transactions

RSUs held after 27,851 units Remaining restricted stock units after conversion

Implied share value for tax $121.48 per share Price used for 1,341-share tax-withholding disposition

RSU vesting schedule 4 years 25% at first anniversary; 6.25% quarterly thereafter

Key Terms

Restricted Stock Unit, vesting schedule, tax-withholding disposition, derivative exercise/conversion, +1 more

5 terms

Restricted Stock Unit financial

"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vesting schedule financial

"The restricted stock units have a 4-year vesting schedule."

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

derivative exercise/conversion financial

"transaction_action: derivative exercise/conversion"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mercier Johanna

(Last) (First) (Middle)

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Comm & Corp Aff Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		M		2,796	A	(1)	128,575	D
Common Stock	06/10/2026		F		1,341	D	$121.48	127,234	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	06/10/2026		M			2,796	(2)	(2)	Common Stock	2,796	(1)	27,851	D

Explanation of Responses:

1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Remarks:

	/s/ Amy Kim by Power of Attorney for Johanna Mercier	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Gilead Sciences officer Johanna Mercier report in this Form 4 for GILD?

Johanna Mercier reported the vesting and exercise of 2,796 restricted stock units into common stock, along with a 1,341-share tax-withholding disposition. These are compensation-related equity transactions rather than open-market trades, reflecting regular management of her stock-based awards.

Did Johanna Mercier buy or sell Gilead Sciences (GILD) shares on the open market?

No open-market purchases or sales were reported. The Form 4 shows an RSU conversion into 2,796 common shares and a 1,341-share tax-withholding disposition. These actions are part of equity compensation mechanics, not discretionary market trading in Gilead Sciences stock.

How many Gilead Sciences shares does Johanna Mercier hold after these Form 4 transactions?

After the reported transactions, Johanna Mercier directly holds 128,575 shares of Gilead Sciences common stock. She also holds 27,851 restricted stock units, which represent contingent rights to receive additional shares as they vest under the company’s equity compensation plan.

What do the restricted stock units (RSUs) in this GILD Form 4 represent?

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences common stock. The RSUs vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining balance vesting 6.25% quarterly until fully vested.

Why were 1,341 Gilead Sciences shares disposed of in Johanna Mercier’s Form 4?

The 1,341-share disposition is coded as a tax-withholding transaction. Shares were delivered to satisfy tax liability associated with the RSU vesting and exercise, which is a common administrative step and not an open-market sale of Gilead Sciences stock by the officer.

How does the RSU vesting schedule work for Johanna Mercier’s Gilead grants?

The RSUs have a four-year vesting schedule: 25% of the award vests on the first anniversary of the grant date. The remaining 75% then vests at 6.25% each quarter, so the full amount becomes earned over the four-year period, aligning compensation with ongoing service.